CSF2 and myeloid sarcoma: Importantly, a seminal study shows that such GM-CSFs predominantly producing Th cells are CXCR4+, have pathogenic features in MS, and expand the spectrum of immune cells overexpressing GM-CSF in MS beyond T and B cells [24].